Use of Ibritumomab Tiuxetan Anti-CD20 Radioimmunotherapy in a Non-Hodgkin's Lymphoma Patient Previously Treated with a Yttrium-90–Labeled Anti-CD22 Monoclonal Antibody
作者
Donald E. Tsai,Ivan Maillard,Stephen J. Schuster,Sunita D. Nasta,David L. Porter,Thomas R. Klumpp,David M. Goldenberg,Selina M. Luger,Abass Alavi,Robert M. Sharkey,Kenneth B. Hartzell,Edward A. Stadtmauer